Good news! Huibang Biology was selected into the list of key cultivars for the biomedical industry in Hefei!

Date：

2023-03-26

 

 

On March 25, the Hefei Biopharmaceutical Industry Supply and Demand Docking and Key Cultivated Variety Release Promotion Conference was held in the Municipal Affairs Center. Wait for the leader to preside over the meeting. Key enterprises in the pharmaceutical industry in Hefei, related medical institutions, pharmaceutical distribution companies, etc. will conduct in-depth docking on the promotion of pharmaceutical products and the expansion of market scale. Huibang Bio's self-developed product "Globin/Urinary Microalbumin/Creatinine Detection Kit (Dry Method)" was successfully selected and promoted as a key project.

 

 

 

Diabetic kidney disease (DKD) is a common complication of diabetes, and its prevalence is about 40%. However, renal puncture will bring great trauma and risk to patients, and it is not convenient for detection and clinical promotion. The "Happoglobin/Urinary Microalbumin/Creatinine Test Kit (Dry Method)" selected this time only needs one drop of urine, and the test result can be obtained in 10 minutes. Among them, urine haptoglobin detection is the first in the world, which solves the difficulties and pain points of early diagnosis of type 2 diabetic kidney injury at home and abroad, and is the gospel of all diabetic patients.

 

The biomedical industry is known as the "sunrise industry that will never decline", and it is one of the strategic emerging industries that Hefei focuses on cultivating. Huibang Biotechnology will take this successful selection as an opportunity to increase exploration and innovation, and help Hefei's biomedical industry continue to develop with high quality.

 

 

 

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.